Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy Now?
Is EWTX a good stock to buy? We came across a bullish thesis on Edgewise Therapeutics, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on EWTX.
Edgewise Therapeutics Inc. (EWTX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | OrbiMed Advisors Samuel Isaly | 15,518,492 | $630,516,330 | 11.68% | |
| 2. | Paradigm Biocapital Advisors Senai Asefaw | 10,215,455 | $415,053,937 | +39% | 7.77% |
| 3. | RA Capital Management Peter Kolchinsky | 8,392,730 | $340,996,620 | -20% | 2.96% |
| 4. | Driehaus Capital Richard Driehaus | 4,728,623 | $192,123,952 | +6% | 1.11% |
| 5. | Perceptive Advisors Joseph Edelman | 4,373,974 | $177,714,564 | -2% | 2.67% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.64 | 10,700 | $199,403.06 | 23,702 | 2025-11-11 | Filing | |
| $20.13 | 124,193 | $2,500,005.09 | 443,792 | 2025-04-03 | Filing | |
| $20.13 | 372,578 | $7,499,995.14 | 14,809,075 | 2025-04-03 | Filing | |
| $20.13 | 124,193 | $2,500,005.09 | 443,792 | 2025-04-03 | Filing | |
| $20.13 | 372,578 | $7,499,995.14 | 14,809,075 | 2025-04-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.41 | 2,919 | $126,703.57 | 8,625 | 2026-08-13 | Filing | |
| $44.52 | 800 | $35,614.00 | 11,544 | 2026-08-12 | Filing | |
| $44.43 | 104 | $4,620.23 | 12,344 | 2026-08-12 | Filing | |
| $43.71 | 2,779 | $121,462.59 | 12,448 | 2026-08-12 | Filing | |
| $43.78 | 2,839 | $124,302.78 | 15,227 | 2026-08-12 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,666 | $108,240 | 0% | |
| 2. | 525 | $21,315 | 0% | |
| 3. | 242 | $9,825 | 0% | |
| 4. | 99 | $4,019 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Edgewise Therapeutics, Inc. (EWTX) Price Target Raised to $59 on Positive HCM Trial Data
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is among the best healthcare stocks.
10 Best Healthcare Stocks to Buy According to Wall Street Analysts
In this article, we will be taking a look at the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. The U.S.
Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline
We recently compiled a list of the 13 Best Stocks to Invest In on Robinhood for Beginners. Edgewise Therapeutics, Inc. is among the best Robinhood stocks.
13 Best Stocks to Invest In on Robinhood for Beginners
In this article, we will be taking a look at the 13 Best Stocks to Invest In on Robinhood for Beginners.
Edgewise Therapeutics, Inc. (EWTX) Outlines Priorities For 2026
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is among the 14 best booming stocks to buy right now. The stock is surging and has gained over 57% in the last three months, as of the close on January 12.
14 Best Booming Stocks to Buy Right Now
This article looks at the 14 Best Booming Stocks to Buy Right Now.
Edgewise Therapeutics (EWTX) Reports Heightened R&D Activity in Q3 2025
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is one of the best small-cap biotech stocks to buy according to analysts. Edgewise Therapeutics, Inc.
10 Best Small-Cap Biotech Stocks to Buy According to Analysts
In this piece, we discuss the 10 Best Small-Cap Biotech Stocks to Buy According to Analysts. Small-cap biotech stocks are marking their latest resurgence, attracting renewed investor attention.
H.C. Wainwright Maintains a Buy on Edgewise Therapeutics (EWTX), Sets a $42 PT
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is one of the best small cap stocks with the highest upside. H.C.
Hedge Fund Resource Center